Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3582238 | 0.83 | ALDH1A1 (0.54) | ALDH1A1SOAT1LMNAHSD17B10ALOX15 | |
| SCHEMBL23189506 | 0.81 | ALDH1A1 (0.52) | ALDH1A1SOAT1LMNAHSD17B10ALOX15 | |
| SCHEMBL23189508 | 0.81 | ALDH1A1 (0.52) | ALDH1A1SOAT1LMNAHSD17B10ALOX15 | |
| SCHEMBL28571244 | 0.79 | ALDH1A1 (0.44) | ALDH1A1SOAT1LMNAHSD17B10TSHR | |
| SCHEMBL4959482 | 0.79 | — | — | |
| SCHEMBL4737398 | 0.79 | — | — | |
| SCHEMBL4740084 | 0.78 | CA12 (0.37) | ALDH1A1LMNAHSD17B10GAAKMT2A | |
| SCHEMBL28589401 | 0.77 | TSHR (0.49) | ALDH1A1LMNATSHRHCAR2NPSR1 | |
| SCHEMBL14890864 | 0.76 | ALDH1A1 (0.57) | ALDH1A1SOAT1LMNAHSD17B10ALOX15 | |
| SCHEMBL1440094 | 0.76 | ALDH1A1 (0.57) | ALDH1A1SOAT1LMNAHSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7378548-B2 | Tertiary amine compounds having an ester structure and processes for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-05-27 | — | — | US | claimed |
| US-20060217570-A1 | Novel Tertiary Amine Compounds Having An Ester Structure And Processes For Preparing The Same | SHIN-ETSU CHEMICAL CO., LTD. | 2006-09-28 | — | — | US | claimed |
| US-7378548-B2 | Tertiary amine compounds having an ester structure and processes for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-05-27 | — | — | US | disclosed |
| EP-1253138-B1 | Novel tertiary amine compounds having an ester structure and processes for preparing same | SHINETSU CHEMICAL CO (JP) | 2007-06-27 | — | — | EP | disclosed |
| US-20060217570-A1 | Novel Tertiary Amine Compounds Having An Ester Structure And Processes For Preparing The Same | SHIN-ETSU CHEMICAL CO., LTD. | 2006-09-28 | — | — | US | disclosed |
| US-7084303-B2 | Tertiary amine compounds having an ester structure and processes for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-08-01 | — | — | US | disclosed |
| US-20020193622-A1 | Novel tertiary amine compounds having an ester structure and processes for preparing same | SHIN-ETSU CHEMICAL CO., LTD. | 2002-12-19 | — | — | US | disclosed |
| EP-1253138-A2 | Novel tertiary amine compounds having an ester structure and processes for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193622-A1 | Novel tertiary amine compounds having an ester structure and processes for preparing same | PHOSPHO1, NAAA, DDAH1 | ALDH1A1 87/4885SOAT1 63/4885LMNA 932/4885 |
| US-20060217570-A1 | Novel Tertiary Amine Compounds Having An Ester Structure And Processes For Preparing The Same | HRH3, HRH4, HRH2 | ALDH1A1 551/4885SOAT1 224/4885LMNA 592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.